Alpha Vee RM US Equity & TB (S:0P0001R31S)
196.71
+6.61
(+3.48%)
USD |
Dec 31 2025
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Annual Total Returns Versus Peers
As of January 22, 2026.
Asset Allocation
| Type | % Net |
|---|---|
| Cash | -- |
| Stock | -- |
| Bond | -- |
| Convertible | -- |
| Preferred | -- |
| Other | -- |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Intuitive Surgical, Inc. | 6.96% | 525.78 | 0.40% |
| Micron Technology, Inc. | 5.28% | 397.02 | 2.03% |
| Progressive Corp. | 5.24% | 206.91 | 1.93% |
| Arista Networks, Inc. | 5.17% | 138.41 | 8.74% |
| Vertex Pharmaceuticals, Inc. | 4.75% | 467.34 | 1.34% |
| Newmont Corp. | 4.42% | 121.68 | 2.33% |
| Accenture Plc | 4.39% | 285.12 | 1.57% |
| Chubb Ltd. | 4.16% | 300.79 | 0.27% |
| EOG Resources, Inc. | 3.09% | 106.26 | -1.66% |
| Regeneron Pharmaceuticals, Inc. | 3.02% | 755.33 | 0.80% |
Fees & Availability
| Fees | |
| Negotiable Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Purchase Details | |
| Open to New Investors | -- |
| Minimum Initial Investment | -- |
| Minimum Subsequent Investment | -- |
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Fundamentals
| General | |
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Number of Equity Holdings | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Attributes | |
| Socially Responsible Fund | -- |